相关实验视频
Updated: Jan 17, 2026
09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
18.5K
卡里指南关于KDIGO临床实践指南的评论,用于管理淋巴细胞疾病
Bhadran Bose1,2, Simon A Carter1,3,4, Mia E Abdy5,6
1Australasian Kidney Trials Network, The University of Queensland, Brisbane, Queensland, Australia.
Nephrology (Carlton, Vic.)
|September 16, 2025
概括
更新的淋巴细胞疾病 (GD) 指南提供了新的诊断和治疗策略. 遗传检测和新疗法在澳大利亚和新西兰有望改善患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 淋巴细胞疾病 淋巴细胞疾病
- 临床指南 临床指南
背景情况:
- "KDIGO 2021年淋巴细胞疾病指南"提供了更新的管理建议.
- 淋巴细胞疾病 (GD) 影响功能,需要当前的治疗策略.
- 诊断和治疗方面的进步旨在改善患有GD的个体的治疗结果.
研究的目的:
- 为澳大利亚和新西兰的KDIGO 2021年淋巴细胞疾病指南提供上下文.
- 突出显示了球细胞疾病的诊断和管理中的关键更新.
- 为临床医生提供有关新兴疗法和诊断工具的信息.
主要方法:
- 关于KDIGO 2021年淋巴细胞疾病指南的评论.
- 为澳大利亚和新西兰环境调整国际准则.
- 对诊断进展和治疗选择的审查.
主要成果:
- 脏活检仍然对诊断至关重要,得到评分系统的支持.
- 基因检测现在可用于单一性脏疾病,有助于早期诊断.
- 为了评估蛋白质分泌量,最好采集定时的尿液;对于25岁以下的人来说,建议使用CKiD u25 eGFR方程.
- 针对IgA病 (IgAN) 和IgA血管炎 (IgAV) 的新兴疗法显示出有前途.
- 针对成人和儿科膜性脏病的具体管理差异.
- 塔克罗利莫斯和利图西马布是治疗性综合征的关键药物.
- 对最小变化疾病和焦点细分质硬化症的建议包括遗传洞察力.
结论:
- 增加临床试验参与对于区域指南的验证至关重要.
- 新药正在等待批准,可能扩大治疗选择.
- 改善球细胞疾病的长期结果取决于指南的实施和研究.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
01:18Chronic Kidney Disease IV: Nursing Management
321
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
321
01:24Chronic Kidney Disease II: Clinical Manifestations
557
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557
01:20Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
01:25Chronic Kidney Disease I: Introduction
573
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
573
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
190
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
190